与用于根除幽门螺杆菌的铋剂四联疗法（Pylera）相关的艰难梭菌感染。 - Suppr | 超能文献

Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylera) for Helicobacter pylori eradication.

作者信息

Castro-Fernández Manuel, Marqués-Ruiz Alberto, Cámara-Baena Sergio, Grande-Santamaría Lourdes

机构信息

Unidad de Gestión Cínica de Enfermedades Digestivas, Hospital Universitario de Valme, Tomares, Sevilla, España.

Unidad de Gestión Cínica de Enfermedades Digestivas, Hospital Universitario de Valme, Tomares, Sevilla, España.

出版信息

Gastroenterol Hepatol. 2019 Aug-Sep;42(7):459-460. doi: 10.1016/j.gastrohep.2019.01.012. Epub 2019 Mar 20.

DOI:10.1016/j.gastrohep.2019.01.012

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylera) for Helicobacter pylori eradication.与用于根除幽门螺杆菌的铋剂四联疗法（Pylera）相关的艰难梭菌感染。

Gastroenterol Hepatol. 2019 Aug-Sep;42(7):459-460. doi: 10.1016/j.gastrohep.2019.01.012. Epub 2019 Mar 20.

2

Pylera for the eradication of Helicobacter pylori infection.用于根除幽门螺杆菌感染的Pylera

Expert Rev Anti Infect Ther. 2009 Sep;7(7):793-9. doi: 10.1586/eri.09.55.

3

Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study.枸橼酸铋钾、甲硝唑和四环素单三联胶囊联合奥美拉唑根除幽门螺杆菌的疗效和安全性：一项国际多中心研究

Aliment Pharmacol Ther. 2003 Feb;17(3):415-20. doi: 10.1046/j.1365-2036.2003.01434.x.

4

[Anti-Helicobacter pylori quadruple therapy].[抗幽门螺杆菌四联疗法]

Nihon Rinsho. 2005 Nov;63 Suppl 11:442-51.

5

Bismuth-based quadruple therapy following H. pylori eradication failures: a multicenter study in clinical practice.幽门螺杆菌根除失败后铋剂四联疗法：一项临床实践中的多中心研究

J Gastrointestin Liver Dis. 2017 Sep;26(3):225-229. doi: 10.15403/jgld.2014.1121.263.zul.

6

Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.幽门螺杆菌在存在青霉素过敏的情况下的一线和挽救治疗。

Dig Dis Sci. 2015 Feb;60(2):458-64. doi: 10.1007/s10620-014-3365-2. Epub 2014 Sep 19.

7

European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice.欧洲幽门螺杆菌管理注册研究：单胶囊铋剂四联疗法在真实临床实践中有效。

United European Gastroenterol J. 2021 Feb;9(1):38-46. doi: 10.1177/2050640620972615. Epub 2021 Feb 11.

8

The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.三联或四联铋剂疗法根除幽门螺杆菌治疗加或不加益生菌补充剂：日常临床实践中的疗效和安全性。

Helicobacter. 2018 Aug;23(4):e12502. doi: 10.1111/hel.12502. Epub 2018 Jun 20.

9

[Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?].[酸相关性疾病。幽门螺杆菌目前的首选挽救治疗方案是什么：四联疗法（质子泵抑制剂、铋剂、四环素和甲硝唑）还是质子泵抑制剂、阿莫西林和左氧氟沙星的三联疗法？]

Gastroenterol Hepatol. 2008 Jun-Jul;31(6):400-1. doi: 10.1157/13123612.

10

Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole.基于铋剂的幽门螺杆菌四联疗法——一种单一三联胶囊加兰索拉唑。

Aliment Pharmacol Ther. 2000 Jan;14(1):85-9. doi: 10.1046/j.1365-2036.2000.00686.x.

引用本文的文献

1

Investigating the relationship between Helicobacter pylori and intestinal Clostridioides difficile infection: evidence from a cross-sectional study.探究幽门螺杆菌与肠道艰难梭菌感染之间的关系：一项横断面研究的证据

BMC Gastroenterol. 2025 Aug 25;25(1):616. doi: 10.1186/s12876-025-04227-w.

2

Relationship between infection and gastrointestinal microecology.感染与胃肠道微生态的关系。

Front Cell Infect Microbiol. 2022 Aug 18;12:938608. doi: 10.3389/fcimb.2022.938608. eCollection 2022.